Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,193,043
-$83,249 QoQ
Shares Held
49,545
+9.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,219
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. PFE ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
This page
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,193,043 | 49,545 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,276,292 | 45,452 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,031,980 | 41,445 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $675,602 | 26,515 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $421,776 | 17,400 | Shares | Sole | 2025-07-16 | |
| 2024-09-30 | $312,552 | 10,800 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $366,538 | 13,100 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $920,634 | 33,176 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,386,555 | 48,161 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $1,791,876 | 54,021 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,809,461 | 49,331 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,074,312 | 50,841 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,465,873 | 48,124 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,880,279 | 42,968 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $2,021,543 | 38,557 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,730,308 | 33,423 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,912,216 | 32,383 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,394,943 | 32,433 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,271,290 | 32,464 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,209,502 | 33,384 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,236,227 | 33,584 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,238,036 | 33,734 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,114,188 | 34,073 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,157,184 | 35,453 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||